RBx 6510
Latest Information Update: 30 Oct 2000
At a glance
- Originator Ranbaxy Laboratories
- Class Antifungals
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 30 Oct 2000 Discontinued-Preclinical for Mycoses in India (Unknown route)
- 26 Jul 2000 New profile
- 26 Jul 2000 Preclinical development for Mycoses in India (Unknown route)